Real-World Outcomes of Olaparib Treatment in Japanese Patients With Metastatic Castration-Resistant Prostate Cancer Harboring BRCA Pathogenic or Likely Pathogenic Variants.
- DOI
- 10.1111/iju.70590
- Published
- 2026-08-01
- Container
- Int J Urol
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/iju.70590,
title = {Real-World Outcomes of Olaparib Treatment in Japanese Patients With Metastatic Castration-Resistant Prostate Cancer Harboring BRCA Pathogenic or Likely Pathogenic Variants.},
author = {Yasuda Y and Yoshida S and Yonese I and Sano Y and Matsumoto S and Urasaki T and Tamiya T and Tanaka H and Ito M and Miura Y and Numao N and Matsuoka Y and Koga F and Yonese J and Fujii Y.},
year = {2026},
journal = {Int J Urol},
doi = {10.1111/iju.70590},
url = {https://doi.org/10.1111/iju.70590}
}RIS
TY - JOUR TI - Real-World Outcomes of Olaparib Treatment in Japanese Patients With Metastatic Castration-Resistant Prostate Cancer Harboring BRCA Pathogenic or Likely Pathogenic Variants. AU - Yasuda Y AU - Yoshida S AU - Yonese I AU - Sano Y AU - Matsumoto S AU - Urasaki T AU - Tamiya T AU - Tanaka H AU - Ito M AU - Miura Y AU - Numao N AU - Matsuoka Y AU - Koga F AU - Yonese J AU - Fujii Y. PY - 2026 JO - Int J Urol DO - 10.1111/iju.70590 UR - https://doi.org/10.1111/iju.70590 ER -
APA
Y, Y., S, Y., I, Y., Y, S., S, M., T, U., T, T., H, T., M, I., Y, M., N, N., Y, M., F, K., J, Y., & Y., F. (2026). Real-World Outcomes of Olaparib Treatment in Japanese Patients With Metastatic Castration-Resistant Prostate Cancer Harboring BRCA Pathogenic or Likely Pathogenic Variants.. Int J Urol. https://doi.org/10.1111/iju.70590
Source records
- europe-pmc · retrieved 2026-09-25T23:37:45.386Z